4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-002595
Director sold 10,000 shares at $42.19 ($421,900)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2020-01-07 | Option exercise | +10,000 | $1.75 | $17,500 | 10,000 | D |
| Brege Laura Director | 2020-01-07 | Sale | −10,000 | $42.19 | $421,900 | 0 | D |
| Derivatives | |||||||
| Brege Laura Director | 2020-01-07 | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | D | ||
| Open-market sales · 10,000 sh · avg $42.19 · $421,900 | |||||||
Loading xslF345X03/doc4.xml…